FAM168A and ovarian carcinoma: We found that expression of TCRP1 in lung cancer, glioma, ovarian cancer, thyroid cancer, nasopharyngeal carcinoma, pancreatic cancer, stomach cancer and tongue carcinoma was significantly higher than that of normal tissue (Figure 6a).